Adverse effect on marketed drugs

Ended Definitive Contract Awarded Last action

Contract number
HHSF223200510006C
Awardee
Awarding agency
Obligated
$1,019,732

Award facts

Contract value 59% obligated
  • $1,353,278.57 Current, with exercised options
  • $1,737,034.57 Potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
541990 All Other Professional, Scientific, and Technical Services
PSC
C118 Research And Development Facilities
Set-aside
No set-aside
Competition
Full and Open Competition · 6 offers Negotiated Proposal / Quote
Pricing
Cost No Fee
Place of performance
Basking Ridge, Bernards, NJ, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Close Out 13 -$677,790
Other Administrative Action 12 $0
Other Administrative Action 11 $0
Supplemental Agreement for work within scope 10 $582,241
Other Administrative Action 9 $0
Other Administrative Action 8 $0
Exercise an Option 7 · New contract for a multiple award cost reimbursement procurement entitled adverse effects of marketed drugs $239,363
Funding Only Action 6 $239,392
Exercise an Option 4 $239,953
Original award $396,573

Quick answers

Who was awarded contract HHSF223200510006C?

HHSF223200510006C was awarded to Optuminsight, Inc. by Food and Drug Administration (Department of Health and Human Services) on September 22, 2005.

How much is contract HHSF223200510006C worth?

The government has obligated $1,019,732 on HHSF223200510006C. Its current value, with exercised options, is $1,353,279. Its potential value, with all options, is $1,737,035.

Was contract HHSF223200510006C competed?

The extent of competition for HHSF223200510006C was full and open competition. The government received 6 offers.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award
Try for free Login